133 Cost-effectiveness of dry-powder mannitol for inhalation as an add-on to best supportive care (BSC) in the treatment of adult cystic fibrosis (CF) patients in Ireland

Matthias Schwenkglenks(University of Basel), Joris van Stiphout(Vencore (United States)), Richéal Burns(University of Oxford), Barbara Dooley(University College Dublin), Toby J. Toward(Pharmaxis (United Kingdom)), Elisabeth J Adams(Aquarius Population Health)
Journal of Cystic Fibrosis
June 1, 2015
Cited by 0


Related Papers